BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

2019 MDA Engage ALS Symposium Event

Saturday, May 18, 2019
Registration & Breakfast: 9:00-10:00am
Event: 10:00-3:30pm (lunch included)
Social Hour: 3:30-4:30pm

Event Chair: Dr. James Berry, Massachusetts General Hospital

Event Location:
Boston Marriott Quincy
1000 Marriott Drive
Quincy, MA 02169

There is no cost to attend the event, however, registration is required.

Registration has Closed

  • Keynote Presentation – Best practice in Clinical Care of ALS
    • Dr. James Berry, MPH, Massachusetts General Hospital
  • Research & Clinical Trial Review for ALS
    • Dr. Robert Brown, DPhil, University of Massachusetts Medical School
  • Drug Development Round Table
    • Moderator – Dr. James Berry, MPH, Massachusetts General Hospital
  • Technology & Supportive Care
    • John Costello, MA, CCC-SLP, University of Massachusetts Medical School and Massachusetts General Hospital
  • Mental Health Considerations
    • The ALS PACT Program
  • National ALS Registry
    • Agency for Toxic Substances and Disease Registry (ATSDR)
  • MDA Spotlight
    • Melissa Immomen, LCSW

Thank you to our supporters

  • AveXis
  • Cytokinetics
  • Genentech
  • Mitsubishi Tanabe Pharma, America

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)